(Q62110542)

English

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

clinical trial

In more languages

Statements

0 references

An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Refractory or Relapsed Multiple Myeloma (English)

0 references

medical condition

multiple myeloma

0 references

United States of America

0 references

May 2004

0 references

number of participants

30

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

research subject recruitment status

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110542&oldid=2149210268"